A Mass Balance Study of DZD8586 in Healthy Male Participants (TAI-SHAN15)

Clinical trial NCT07454863 · COMPLETED

Trial details

NCT number: NCT07454863
Sponsor: Dizal Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin

Start date: 2026-03-16
Primary completion: 2026-03-27
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.